Andrey Arzumanov

University of OxfordUnited Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index2.7kcitations74works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

RNA Interference and Gene Delivery(39), DNA and Nucleic Acid Chemistry(36), Advanced biosensing and bioanalysis techniques(31), HIV/AIDS drug development and treatment(18), Biochemical and Molecular Research(12)

Publications74 total

Systemic Delivery of Peptide-Conjugated Antisense Oligonucleotides Leads to Long-Lasting Correction of Myotonic Dystrophy Type I
HAL (Le Centre pour la Communication Scientifique Directe)·2019
Low-dose of peptide-conjugate antisense oligonucleotides targeting CUGexp-RNA in murine skeletal muscles normalizes Myotonic Dystrophy 1 phenotype
HAL (Le Centre pour la Communication Scientifique Directe)·2019
Oxford University Research Archive (ORA) (University of Oxford)·2018Open Access
Enhanced systemic delivery of antisense oligonucleotides using cell-penetrating peptide to reverse RNA toxicity in DM1
HAL (Le Centre pour la Communication Scientifique Directe)·2017
Methods in molecular biology·2012· 42 cited
Novel cell penetrating peptides for skeletal and cardiac muscle delivery of PMO antisense oligonucleotides for the treatment of duchenne muscular dystrophy.
View·2011
page 1 of 4Next →

Frequent Co-authors

Michael J. Gait(38), Matthew J. A. Wood(11), Bernard Lebleu(10), Gabriela D. Ivanova(8), Rachida Abes(8), Jean‐Jacques Toulmé(7), Alexander A. Krayevsky(7), Suzan M. Hammond(6), Amer F. Saleh(6), Saïd Abes(6), John J. Turner(5), Gabriela Ivanova(5), Natalia Dyatkina(5), Corinne Betts(4), HaiFang Yin(4), Donna Williams(4), Jesper Wengel(4), Dmitry A. Stetsenko(4), Lyubov S. Victorova(4), Sandrine Reigadas(4)